Novocure developed the Optune wearable device to deliver Tumor Treating Fields, electric fields that slow or stop cancer cells from dividing. [Photo courtesy of Novocure]
An innovative device harnesses the power of electric fields to disrupt solid tumor cell division.By Bill Doyle, Novocure
For more than 20 years, Novocure has been at the forefront of innovation, pioneering biophysical cancer treatments. With the invention and development of Tumor Treating Fields therapy, Novocure is striving to extend survival in some of the most aggressive forms of cancer.
In modern medicine, cancer treatment has relied on combinations of surgery, ionizing radiation, and drugs — each of which can come with challenging side effects. In 2011, the FDA approved a first-of-its-kind medical device for recurrent glioblastoma that changed cancer therapy expectations with its novel mechanism of action for killing cancer ce…